Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyaluronic acid (HA) is a high-molecular-weight, non-sulfated glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, found extensively throughout the extracellular matrix of connective, epithelial, and neural tissues (PubChem CID 24759). It plays a fundamental role in maintaining tissue hydration and osmotic balance due to its exceptional water-binding capacity, while also providing essential lubrication in synovial joints. Beyond its structural contributions, HA serves as a dynamic signaling molecule by interacting with cell surface receptors such as CD44 and the Receptor for Hyaluronan-Mediated Motility (RHAMM), which regulate cell proliferation, migration, and inflammatory responses (PubMed PMID: 30235439). In pathological conditions like cancer, the over-accumulation of HA in the tumor stroma increases interstitial fluid pressure, creating a physical barrier that hinders the delivery and efficacy of chemotherapeutic agents (PubMed PMID: 29439110). Therapeutic interventions targeting HA include the use of hyaluronidases to degrade the matrix and improve drug penetration, as well as the administration of exogenous HA as a viscosupplement to restore joint function in osteoarthritis (StatPearls NBK482440).
Enzymatic degradation of hyaluronic acid to reduce interstitial fluid pressure and enhance drug diffusion; supplementation of synovial fluid to provide mechanical lubrication and shock absorption; inhibition of hyaluronan synthase to prevent pathological accumulation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyaluronic acid (HA) (HA).